US Stock MarketDetailed Quotes
Dyne Therapeutics (DYN)
- 19.810
- +0.810+4.26%
Close Apr 14 16:00 ET
- 19.649
- -0.161-0.81%
Post 20:01 ET
3.27BMarket Cap-5.71P/E (TTM)
19.990High18.890Low2.28MVolume19.150Open19.000Prev Close44.89MTurnover1.47%Turnover RatioLossP/E (Static)165.03MShares25.00052wk High3.36P/B3.08BFloat Cap8.01052wk Low--Dividend TTM155.35MShs Float47.450Historical High--Div Yield TTM5.79%Range %4.300Historical Low19.689Avg Price1Lot Size
Dyne Therapeutics (DYN) Key Financial Indicators
DYN Earnings per Share (EPS)
According to the latest financial report of Dyne Therapeutics, the latest earnings per share (TTM) for the company is -0.76. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
DYN Free Cash Flow (FCF)
Interested in knowing about Dyne Therapeutics's free cash flow? The latest report shows it as -112.32M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
DYN Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Dyne Therapeutics shows that the company's current ratio is 22.25, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
DYN Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Dyne Therapeutics, the quick ratio is 21.94, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
DYN Return on Equity (ROE)
Want to learn more about the financial health of Dyne Therapeutics? The latest ROE figure is -13.46%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
DYN Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Dyne Therapeutics, the total asset return on investment (ROA) is -10.90%.
Currency: USD
Quarterly
Loading...
DYN Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Dyne Therapeutics's latest financial report to see how their gross margin is doing - currently at 28.87%.
Currency: USD
Quarterly
Loading...
DYN Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Dyne Therapeutics, the net profit margin is -9.56%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...